Psoriatic Arthritis
News
Secukinumab bests etanercept, placebo for sustained improvement of psoriasis
Key clinical point: The study findings validate interleukin-17A as a therapeutic target for moderate to severe plaque psoriasis, and a majority of...
News
Arthritis drug restores hair in man with alopecia universalis and psoriasis
News
Arthritis drug restores hair in man with alopecia universalis and psoriasis
News
Metabolic syndrome, insulin resistance occur frequently in psoriatic arthritis patients
Key clinical point: The presence of metabolic syndrome or insulin resistance may be a marker for more severe psoriatic arthritis.Major finding:...
News
Psoriasis risk rises in women with history of hypertension and beta-blocker use
Key clinical point: Women with a long history of hypertension, or a long history of beta-blocker use to treat hypertension, may be at increased...
News
Foundation turns spotlight on psoriatic arthritis
News
Low infliximab start dose appears effective in psoriatic arthritis
Key clinical point: Most patients with psoriatic arthritis fare well on a lower than recommended starting dose.Major finding: Median starting...
Conference Coverage
Treat to target shows durable improvements in psoriatic arthritis
News
Brodalumab outperformed placebo for psoriatic arthritis
Key clinical point: Interleukin-17 receptor A is a potential treatment target in psoriatic arthritis patients, whether or not they have received...
Conference Coverage
Apremilast appears to have multiple, lasting benefits in psoriatic arthritis
Key clinical point: Apremilast maintained its efficacy and safety profile through 1 year of treatment.Major finding: At 52 weeks, 55%-63% of...